180 related articles for article (PubMed ID: 37106379)
1. The β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance.
Huang WJ; Guo SB; Shi H; Li XL; Zhu Y; Li M; Song LY; Yu RM; Cai QQ; Tian XP
J Exp Clin Cancer Res; 2023 Apr; 42(1):105. PubMed ID: 37106379
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
3. The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
Huang WJ; Tian XP; Bi SX; Zhang SR; He TS; Song LY; Yun JP; Zhou ZG; Yu RM; Li M
Oncogene; 2020 Jun; 39(23):4538-4550. PubMed ID: 32372060
[TBL] [Abstract][Full Text] [Related]
4. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
5. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
Liu X; Liu X; Wu Y; Fang Z; Wu Q; Wu C; Hao Y; Yang X; Zhao J; Li J; Wang Q; Yang Z; Xu J; Hu X; Tan M; Li L
Cell Physiol Biochem; 2018; 48(1):87-98. PubMed ID: 30001529
[TBL] [Abstract][Full Text] [Related]
7. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
8. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
Song X; Wang H; Wu J; Sun Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
[No Abstract] [Full Text] [Related]
11. miR-371b-5p promotes cell proliferation, migration and invasion in non-small cell lung cancer via SCAI.
Luo X; Zhang X; Peng J; Chen Y; Zhao W; Jiang X; Su L; Xie M; Lin B
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33103723
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long non-coding RNA LEF1-AS1 attenuates apoptosis and inflammatory injury of microglia cells following spinal cord injury.
Cui SY; Zhang W; Cui ZM; Yi H; Xu DW; Liu W; Zhu XH
J Orthop Surg Res; 2021 Jan; 16(1):6. PubMed ID: 33407665
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma.
Fan FY; Deng R; Yi H; Sun HP; Zeng Y; He GC; Su Y
Int J Oncol; 2017 Jul; 51(1):316-326. PubMed ID: 28534937
[TBL] [Abstract][Full Text] [Related]
15. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
[TBL] [Abstract][Full Text] [Related]
16. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH
J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973
[TBL] [Abstract][Full Text] [Related]
18. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
Zhou C; Yi C; Yi Y; Qin W; Yan Y; Dong X; Zhang X; Huang Y; Zhang R; Wei J; Ali DW; Michalak M; Chen XZ; Tang J
Mol Cancer; 2020 Jul; 19(1):118. PubMed ID: 32727463
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA hsa_circ_0001829 promotes gastric cancer progression through miR-155-5p/SMAD2 axis.
Niu Q; Dong Z; Liang M; Luo Y; Lin H; Lin M; Zhong X; Yao W; Weng J; Zhou X
J Exp Clin Cancer Res; 2020 Dec; 39(1):280. PubMed ID: 33308284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
